Prostanoid Receptors
Products Related to Prostanoid Receptors(25)
- GC11067PF 04418948CAS: 1078166-57-0Purity: >98.50%
PF 04418948 is an orally active, potent, and selective prostaglandin EP2 receptor antagonist with an IC 50 value of 16nM.
- GC12101EpoprostenolCAS: 61849-14-7Purity: >96.00%
Epoprostenol is a synthetic analogue of the naturally occurring eicosanoid prostacyclin.
- GC15622Dinoprost (Prostaglandin F2a) tromethamine saltCAS: 38562-01-5Purity: >98.00%
Prostaglandin F2α (Prostaglandin F2α tromethamine salt) is an orally active, potent prostaglandin F (PGF) receptor (FP receptor) agonist.
- GC15948Prostaglandin E2CAS: 363-24-6Purity: >98.00%
Prostaglandin E2 is a major metabolite produced from arachidonic acid catalyzed by Cyclooxygenase (COX).
- GC16838(±)-Cloprostenol sodium saltCAS: 55028-72-3Purity: >98.50%
prostaglandin F2α (PGF2α) analog,FP receptor agonist
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC10304 | L-798,106 | 244101-02-8 | >99.50% | |
prostanoid EP3 receptor antagonist | ||||
| GC11067 | PF 04418948 | 1078166-57-0 | >98.50% | |
PF 04418948 is an orally active, potent, and selective prostaglandin EP2 receptor antagonist with an IC 50 value of 16nM. | ||||
| GC11122 | TCS 2510 | 346673-06-1 | >98.00% | |
EP4 agonist | ||||
| GC11133 | 16,16-Dimethyl Prostaglandin E2 | 39746-25-3 | - | |
derivative of prostaglandin E2 | ||||
| GC11820 | BMY 45778 | 152575-66-1 | >98% | |
partial agonist at IP1 prostacyclin receptors | ||||
| GC12101 | Epoprostenol | 61849-14-7 | >96.00% | |
Epoprostenol is a synthetic analogue of the naturally occurring eicosanoid prostacyclin. | ||||
| GC12750 | (+)-Fluprostenol | 54276-17-4 | >98% | |
Prostaglandin F2α (FP) receptor agonist | ||||
| GC13067 | L-655,240 | 103253-15-2 | >98% | |
thromboxane A2/prostaglandin endoperoxide receptor antagonist | ||||
| GC13165 | SC 51089 | 146033-02-5 | >98% | |
EP1 prostanoid receptor antagonist | ||||
| GC13205 | U 46619 | 56985-40-1 | >98.00% | |
Selective agonist of PGH2/TxA2 (TP) receptor | ||||
| GC13609 | L-670,596 | 121083-05-4 | >98% | |
thromboxane A2/prostaglandin endoperoxide receptor antagonist | ||||
| GC13732 | TG4-155 | 1164462-05-8 | >99.50% | |
brain penetrant EP2 antagonist | ||||
| GC14128 | SC 19220 | 19395-87-0 | >98% | |
EP1 receptor antagonist | ||||
| GC14173 | L-161,982 | 147776-06-5 | >95.00% | |
EP4 receptor antagonist | ||||
| GC14812 | GW 627368 | 439288-66-1 | >99.50% | |
prostanoid EP4 receptor antagonist | ||||
| GC15157 | SC 51322 | 146032-79-3 | >98.00% | |
EP1 prostanoid receptor antagonist | ||||
| GC15622 | Dinoprost (Prostaglandin F2a) tromethamine salt | 38562-01-5 | >98.00% | |
Prostaglandin F2α (Prostaglandin F2α tromethamine salt) is an orally active, potent prostaglandin F (PGF) receptor (FP receptor) agonist. | ||||
| GC15911 | Iloprost | 78919-13-8 | >98.00% | |
Iloprost is a prostacyclin (PGI2) analog that affects platelet aggregation. | ||||
| GC15948 | Prostaglandin E2 | 363-24-6 | >98.00% | |
Prostaglandin E2 is a major metabolite produced from arachidonic acid catalyzed by Cyclooxygenase (COX). | ||||
| GC16639 | NS 304 | 475086-01-2 | >99.50% | |
NS 304 (NS-304) is an orally available and potent agonist for the Prostacyclin (PGI2) receptor (IP receptor). | ||||
| GC16838 | (±)-Cloprostenol sodium salt | 55028-72-3 | >98.50% | |
prostaglandin F2α (PGF2α) analog,FP receptor agonist | ||||
| GC17224 | AH 23848 (calcium salt) | 81496-19-7 | >98% | |
dual antagonist of TP1 and EP4 receptors | ||||
| GC17410 | S18886 | 165538-40-9 | >98.00% | |
S18886 is a thromboxane-prostaglandin receptor antagonist. | ||||
| GC17861 | Sulprostone | 60325-46-4 | >98.00% | |
EP3 and EP1 receptor agonist | ||||
